Paolo Mazzeo
Overview
Explore the profile of Paolo Mazzeo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Functional apoptosis profiling reveals vulnerabilities in T-cell large granular lymphocytic leukemia
Shumilov E, Mazzeo P, Trautmann M, Levien L, Menck K, Richter K, et al.
Ann Hematol
. 2025 Feb;
104(1):581-591.
PMID: 39912943
T-cell large granular lymphocytic leukemia (T-LGLL) is a rare hematologic neoplasm characterized by clonal expansion of CD3 + cytotoxic T lymphocytes and a highly heterogeneous clinical course. Conventional therapy primarily...
2.
Shumilov E, Wurm-Kuczera R, Kerkhoff A, Wang M, Melchardt T, Holtick U, et al.
Blood Adv
. 2024 Dec;
PMID: 39661985
Glofitamab, a bispecific antibody targeting CD20 and CD3, is approved for relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL) after at least two prior treatment lines, but real-world data is scarce....
3.
Shumilov E, Levien L, Mazzeo P, Jung W, Leha A, Koch R, et al.
Leuk Lymphoma
. 2024 Dec;
:1-12.
PMID: 39660415
Allogeneic stem cell transplantation (alloSCT) represents a curative option for patients with relapsed/refractory (r/r) aggressive lymphomas. We compared outcomes of alloSCT in r/r PTCL and r/r DLBCL pts ( = ...
4.
Mazzeo P, Ganster C, Wiedenhoft J, Shirneshan K, Rittscher K, Brzuszkiewicz E, et al.
Hemasphere
. 2024 Sep;
8(9):e70014.
PMID: 39315323
The acquisition of subsequent genetic lesions (clonal evolution, CE) and/or the expansion of existing clones (CEXP) contributes to clonal dynamics (CD) in myelodysplastic syndromes (MDS). Although CD plays an important...
5.
von Jan J, Timonen S, Braun T, Jiang Q, Ianevski A, Peng Y, et al.
Blood
. 2024 Jun;
144(15):1595-1610.
PMID: 38941598
T-prolymphocytic leukemia (T-PLL) is a mature T-cell neoplasm associated with marked chemotherapy resistance and continued poor clinical outcomes. Current treatments, that is, the CD52-antibody alemtuzumab, offer transient responses, with relapses...
6.
Shumilov E, Mazzeo P, Ghandili S, Kunstner A, Weidemann S, Banz Y, et al.
Ann Hematol
. 2024 Jan;
103(5):1587-1599.
PMID: 38194088
Blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare malignancy derived from plasmacytoid dendritic cells, can mimic both acute leukemia and aggressive T-cell lymphoma. Therapy of this highly aggressive hematological disease...
7.
Shumilov E, Boyadzhiev H, Mazzeo P, Akhoundova D, Daskalakis M, Novak U, et al.
Hemasphere
. 2023 Dec;
7(12):e984.
PMID: 38044958
Efficacy and toxicity of chimeric antigen receptor T (CAR-T) cell therapy in relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL) with central nervous system (CNS) involvement remain understudied. Here we analyzed...
8.
Eder L, Martinovic D, Mazzeo P, Ganster C, Hasenkamp J, Thomson J, et al.
Curr Oncol
. 2023 Jan;
30(1):1146-1150.
PMID: 36661736
We present the case of a 64-year-old man diagnosed with large B-cell lymphoma who relapsed twice after standard-of-care therapy. Due to persisting cytopenia, Next generation sequencing analysis was performed, revealing...
9.
Shumilov E, Hasenkamp J, Maulhardt M, Mazzeo P, Schmidt N, Boyadzhiev H, et al.
Hematol Oncol
. 2022 Apr;
40(4):763-776.
PMID: 35368106
Second allogeneic stem cell transplantation (allo-SCT2) represents a rescue option for selected patients (pts) with relapsed/refractory (r/r) acute myeloid leukemia (AML). Still, relapse rates post-allo-SCT2 remain high and effective anti-relapse...
10.
Shumilov E, Mazzeo P, Zinkernagel M, Legros M, Porret N, Romagna L, et al.
Curr Oncol
. 2022 Feb;
29(2):766-776.
PMID: 35200564
Intraocular lymphoma (IOL) presents a real challenge in daily diagnostics. Cyto- and/or histopathology of vitreous body represent the diagnostic cornerstones. Yet, false negative results remain common. Therefore, we analyzed the...